Skip to main content

Equibles does not estimate personal net worth.

Get an email with a short summary when Talphera, Inc. publishes a filing, an earnings call transcript or a press release.

Get TLPH alerts

About Shakil Aslam

Talphera, Inc. reported in an 8-K filed August 14, 2024 that Shakil Aslam was appointed Chief Development Officer, effective May 20, 2024. Talphera, Inc. reported in an 8-K filed August 14, 2024 that Shakil Aslam was appointed Chief Medical Officer. The proxy statement of Talphera, Inc. reports total compensation of $654,840 for Shakil Aslam in fiscal 2025, including a base salary of $473,200. Disclosed compensation is on record for 2 fiscal years. Shakil Aslam has spoken on 3 earnings calls across 1 company, most recently for Talphera, Inc. on November 12, 2026. Talphera, Inc. is classified in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. Other leadership on record at Talphera, Inc. includes Vincent J. Angotti (CEO and Board Member), Raffi Asadorian (CFO), Abhinav Jain (Board Member) and 7 others.

“Dr. Shakil Aslam joined Talphera effective May 20, 2024 as Chief Development Officer.”
Talphera, Inc. Form 8-K, filed August 14, 2024 · Read the filing
“Upon Dr. Palmer's retirement, Dr. Shakil Aslam, currently the Company's Chief Development Officer, will assume the position of the Company's Chief Medical Officer.”
Talphera, Inc. Form 8-K, filed August 14, 2024 · Read the filing

Shakil Aslam on recent calls

“Sure, so... So there have been at least three studies attempted in this space, and those are all based on citrate regional anticoagulant. There was one study started by Vantiv that spun off from Baxter, and that started in around 2016.”
Other, Talphera, Inc. Q3 FY2026 Earnings Call ·
“I am very pleased with the progress we are seeing in the NephroCRRT study as we move toward completing enrollment later this year. We have completed the realignment of sites to match our target profile.”
Other, Talphera, Inc. Q2 FY2026 Earnings Call ·
“So, when we talk to the PIs and the investigators and then as well as the nurses who are running this study and who are doing testing and looking at some of the test results.”
Other, Talphera, Inc. Q1 FY2026 Earnings Call ·

Affiliation history

Company network

Leadership on record at Talphera, Inc.

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2025 Talphera, Inc. (TLPH) $473,200 $654,840
2024 Talphera, Inc. (TLPH) $281,215 $529,242

Recent activity